🕵️ Aptevo Therapeutics Inc. ($APVO)
SEC insider & ownership activity, last 12 months · CIK 1671584 · every row links its SEC filing
Over the last 12 months insiders bought $20K with no open-market selling against it. Grant Grady III bought $20K in discretionary trades (Nov). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $20K (1 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Grant Grady III | 1 | $20K | 0 | – | Nov 10, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Niowave, Inc. | 12.2% | 13G | Jun 22, 2026 | filing ↗ | |
| Ayrton Capital LLC | 10.0% | 13G | Aug 13, 2025 | filing ↗ | |
| ALTO Opportunity Master Fund, SPC - Segregated Master Portfolio B | 10.0% | 13G | Aug 13, 2025 | filing ↗ | |
| Waqas Khatri | 10.0% | 13G | Aug 13, 2025 | filing ↗ | |
| YA II PN, Ltd. | 10.0% | 13G | Jul 8, 2025 | filing ↗ | |
| YA Global Investments II (U.S.), LP | 10.0% | 13G | Jul 8, 2025 | filing ↗ | |
| Yorkville Advisors Global, LP | 10.0% | 13G | Jul 8, 2025 | filing ↗ | |
| Yorkville Advisors Global II, LLC | 10.0% | 13G | Jul 8, 2025 | filing ↗ | |
| YAII GP, LP | 10.0% | 13G | Jul 8, 2025 | filing ↗ | |
| YAII GP II, LLC | 10.0% | 13G | Jul 8, 2025 | filing ↗ | |
| Mark Angelo | 10.0% | 13G | Jul 8, 2025 | filing ↗ | |
| Sc-Sigma Global Partners, LP | 10.0% | 13G | Jul 8, 2025 | filing ↗ | |
| Bigger Capital Fund L P | 9.9% | 13G | Jun 25, 2025 | filing ↗ | |
| Bigger Capital Fund GP, LLC | 9.9% | 13G | Jun 25, 2025 | filing ↗ | |
| Bigger Michael | 9.9% | 13G | Jun 25, 2025 | filing ↗ | |
| CVI Investments, Inc. | 8.2% | 13G | Feb 17, 2026 | filing ↗ | |
| Heights Capital Management, Inc. | 8.2% | 13G | Feb 17, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Other events (8.01) | Jul 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 27, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 29, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 29, 2026 | filing ↗ |
| Material agreement (1.01) | May 25, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | May 25, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 25, 2026 | filing ↗ |
| Earnings (2.02) | May 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 13, 2026 | filing ↗ |
| Other events (8.01) | May 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 6, 2026 | filing ↗ |
| Earnings (2.02) | Mar 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 26, 2026 | filing ↗ |
| Other events (8.01) | Mar 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 10, 2026 | filing ↗ |
| Shareholder vote (5.07) | Feb 18, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 30, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 8, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jan 8, 2026 | filing ↗ |
| Other events (8.01) | Jan 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 8, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Dec 29, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 29, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 9, 2025 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 30, 2025 | filing ↗ |